Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

NCT07291297 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma Metastatic
Sarcoma, Soft Tissue

Interventions

DRUG: Metformin Hydrochloride ER

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]
[object Object]